Recent trends in mortality rates for four major cancers, by sex and race/ethnicity--United States, 1990-1998
- PMID: 11843259
Recent trends in mortality rates for four major cancers, by sex and race/ethnicity--United States, 1990-1998
Abstract
In 1998, 53% of all cancer-related deaths in the United States were associated with four sites: lung/bronchus, colon/rectum, prostate, and female breast. Cancer-related death does not affect racial/ethnic populations similarly. In 1996, the National Cancer Institute (NCI) published cancer incidence and death rates during 1988-1992 in 10 categories of race/ethnicity. To examine trends during 1990-1998 in annual death rates for the four major cancers by sex and race/ethnicity (i.e., blacks, whites, Hispanics, American Indians/Alaska Natives [AI/ANs], and Asians/Pacific Islanders [APIs]), CDC analyzed data from the National Center for Health Statistics' National Vital Statistics System. This report summarizes the results of that analysis, which indicated that, except for lung cancer in women and lung, colorectal, and breast cancer in AI/ANs, trends in death rates from these cancers have generally declined. But the rates remained high for blacks, have not decreased equally among all populations, and have increased in certain instances. Continuing research and prevention efforts are needed to reach high-risk and underserved populations and to understand the reasons for differences in cancer mortality among racial/ethnic populations.
Similar articles
-
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289. J Natl Cancer Inst. 2005. PMID: 16204691
-
Cancer mortality surveillance--United States, 1990-2000.MMWR Surveill Summ. 2004 Jun 4;53(3):1-108. MMWR Surveill Summ. 2004. PMID: 15179359
-
Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.Cancer. 2009 May 1;115(9):1967-76. doi: 10.1002/cncr.24216. Cancer. 2009. PMID: 19235249
-
Breast cancer statistics, 2013.CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1. CA Cancer J Clin. 2014. PMID: 24114568 Review.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
-
Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models.Cancer Gene Ther. 2006 Jan 1;13(1):82-90. doi: 10.1038/sj.cgt.7700863. Cancer Gene Ther. 2006. PMID: 16037823 Free PMC article.
-
The role of vitamin D in cancer prevention.Am J Public Health. 2006 Feb;96(2):252-61. doi: 10.2105/AJPH.2004.045260. Epub 2005 Dec 27. Am J Public Health. 2006. PMID: 16380576 Free PMC article. Review.
-
Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005.Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2170-5. doi: 10.1158/1055-9965.EPI-09-0104. Epub 2009 Jul 21. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19622721 Free PMC article.
-
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees.Am J Prev Med. 2010 Feb;38(2):184-91. doi: 10.1016/j.amepre.2009.10.037. Am J Prev Med. 2010. PMID: 20117575 Free PMC article.
-
Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review.World J Surg Oncol. 2018 Mar 22;16(1):63. doi: 10.1186/s12957-018-1345-2. World J Surg Oncol. 2018. PMID: 29566711 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical